Lee Rosebush

Lee Rosebush

BakerHostetler

Contact  |  View Bio  |  RSS

Latest Publications

Share:

DEA Authorizes Take-Back Programs for Pharmacies

The U.S. Drug Enforcement Administration (DEA) recently issued a Final Rule expanding the facilities that can collect unused prescription drugs to now include retail pharmacies, hospitals and pharmaceutical manufacturers, as...more

9/15/2014 - DEA Pharmaceutical Pharmacies Prescription Drugs

Implications on Pharmacies of Recent OIG Advisory Opinion on Per-Fill Fees

The U.S. Department of Health & Human Services, Office of Inspector General (OIG) recently issued an advisory opinion regarding a proposed arrangement by a specialty pharmacy (Requestor) to pay local pharmacies a per-fill fee...more

9/10/2014 - Anti-Kickback Statute Fees Healthcare HHS OIG Pharmacies

The Orphan Drug Wars: HHS Interpretive Rule Clarifies Orphan Drug Exclusion

On July 21, 2014, the U.S. Department of Health and Human Services (HHS) released an “Interpretive Rule” in response to a recent U.S. District Court decision that vacated the July 23, 2013, orphan drug rule on the grounds...more

7/23/2014 - 340B FFDCA HHS Orphan Drugs PHRMA PHSA Prescription Drugs

FDA Releases Compounding Policy Documents

The U.S. Food and Drug Administration (FDA) has released five policy documents regarding compounded human drug products in connection with its continued implementation of the compounding provisions of the Drug Quality and...more

7/3/2014 - DQSA Drug Compounding Drug Manufacturers FDA FFDCA Manufacturers Prescription Drugs

The Orphan Drug Wars: HHS’s Rebuttal to Its Recent Loss to PhRMA

On June 18, 2014, the U.S. Department of Health and Human Services (HHS) publicly stated that the recent decision of the U.S. District Court for the District of Columbia to vacate HHS’s regulation covering orphan drugs and...more

6/24/2014 - Final Rules Healthcare HHS Orphan Drugs Pharmaceutical PHRMA Section 340B

Stop the Presses! Senate Directs FDA to Meet With Stakeholders Before Enforcing Compounding Law

As previously discussed, the recent flurry of U.S. Food and Drug Administration (FDA) activity following passage of the Drug Quality and Security Act (DQSA) in November 2013, including the issuance of three draft guidance...more

5/29/2014 - DQSA Drug Compounding Enforcement FDA Pharmaceutical Pharmacies Prescription Drugs

FDA Regulation of Compounding Pharmacies: Unsolved Mysteries

The U.S. Food and Drug Administration (FDA) has been busy since the passage of the Drug Quality and Security Act (DQSA) in November 2013. In just five short months, the FDA has issued six warning letters referencing the...more

5/5/2014 - DQSA Drug Compounding FDA FFDCA Interstate Commerce Pharmacies

Special Edition: Health Law Update: Senate Passes "Drug Quality and Security Act"

On November 18, 2013, the Senate, by voice vote, approved the Drug Quality and Security Act (DQSA), intended to bolster the Food and Drug Administration's (FDA) oversight of compounding pharmacies in light of last year's...more

11/20/2013 - Compliance DQSA Drug Compounding Drug Manufacturers FDA FFDCA Pharmaceutical Pharmacies Prescription Drugs

Regulation of Compounding Pharmacies Continues to Evolve with House Passage of "Drug Quality and Security Act"

In the current environment it seems that few, if any, pieces of legislation are moving through Capitol Hill. However, there is one area that has seen significant activity: the regulation of compounding pharmacies....more

10/9/2013 - Drug Compounding FDA Pharmacies

After Recalls, Pharmacies Wonder How Well They REALLY Know Their Subcontractors

Pharmacy compounding has been a very hot topic over the last 12 months. Whether it is news from Capitol Hill regarding possible legislation, regulation from the Food and Drug Administration (FDA) or action by a state board of...more

9/20/2013 - Drug Compounding FDA Pharmacies Prescription Drugs Product Recalls Subcontractors

10 Results
|
View per page
Page: of 1